Literature DB >> 11000232

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.

C W Mandl1, S L Allison, H Holzmann, T Meixner, F X Heinz.   

Abstract

The impact of a specific region of the envelope protein E of tick-borne encephalitis (TBE) virus on the biology of this virus was investigated by a site-directed mutagenesis approach. The four amino acid residues that were analyzed in detail (E308 to E311) are located on the upper-lateral surface of domain III according to the X-ray structure of the TBE virus protein E and are part of an area that is considered to be a potential receptor binding determinant of flaviviruses. Mutants containing single amino acid substitutions, as well as combinations of mutations, were constructed and analyzed for their virulence in mice, growth properties in cultured cells, and genetic stability. The most significant attenuation in mice was achieved by mutagenesis of threonine 310. Combining this mutation with deletion mutations in the 3'-noncoding region yielded mutants that were highly attenuated. The biological effects of mutation Thr 310 to Lys, however, could be reversed to a large degree by a mutation at a neighboring position (Lys 311 to Glu) that arose spontaneously during infection of a mouse. Mutagenesis of the other positions provided evidence for the functional importance of residue 308 (Asp) and its charge interaction with residue 311 (Lys), whereas residue 309 could be altered or even deleted without any notable consequences. Deletion of residue 309 was accompanied by a spontaneous second-site mutation (Phe to Tyr) at position 332, which in the three-dimensional structure of protein E is spatially close to residue 309. The information obtained in this study is relevant for the development of specific attenuated flavivirus strains that may serve as future live vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000232      PMCID: PMC112392          DOI: 10.1128/jvi.74.20.9601-9609.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Functional cDNA clones of the Flaviviridae: strategies and applications.

Authors:  N Ruggli; C M Rice
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus.

Authors:  F X Heinz; W Tuma; F Guirakhoo; C Kunz
Journal:  J Biol Stand       Date:  1986-04

3.  Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.

Authors:  B Lin; C R Parrish; J M Murray; P J Wright
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

4.  Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

Authors:  C S Hahn; J M Dalrymple; J H Strauss; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.

Authors:  A D Jennings; C A Gibson; B R Miller; J H Mathews; C J Mitchell; J T Roehrig; D J Wood; F Taffs; B K Sil; S N Whitby
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

6.  A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.

Authors:  F X Heinz; R Berger; W Tuma; C Kunz
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

7.  Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.

Authors:  M Lobigs; R Usha; A Nestorowicz; I D Marshall; R C Weir; L Dalgarno
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  Identification of naturally occurring monoclonal antibody escape variants of louping ill virus.

Authors:  G F Gao; M H Hussain; H W Reid; E A Gould
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

9.  Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence.

Authors:  W R Jiang; A Lowe; S Higgs; H Reid; E A Gould
Journal:  J Gen Virol       Date:  1993-05       Impact factor: 3.891

10.  Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility.

Authors:  T Kimura; J Kimura-Kuroda; K Nagashima; K Yasui
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more
  51 in total

1.  Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

Authors:  S Bhardwaj; M Holbrook; R E Shope; A D Barrett; S J Watowich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence.

Authors:  Regina M Kofler; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.

Authors:  Regina M Kofler; Agnes Leitner; Gabriel O'Riordain; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Authors:  David W C Beasley; Alan D T Barrett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line.

Authors:  Rainer Gehrke; Michael Ecker; Stephan W Aberle; Steven L Allison; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.